| Comprehensive characterization of cancer driver genes and mutations MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cell 173 (2), 371-385. e18, 2018 | 2146 | 2018 |
| Pathogenic germline variants in 10,389 adult cancers K Huang, RJ Mashl, Y Wu, DI Ritter, J Wang, C Oh, M Paczkowska, ... Cell 173 (2), 355-370. e14, 2018 | 707 | 2018 |
| Proteogenomic characterization reveals therapeutic vulnerabilities in lung adenocarcinoma MA Gillette, S Satpathy, S Cao, SM Dhanasekaran, SV Vasaikar, K Krug, ... Cell 182 (1), 200-225. e35, 2020 | 461 | 2020 |
| Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 179 (4), 964-983. e31, 2019 | 447 | 2019 |
| Proteogenomic and metabolomic characterization of human glioblastoma LB Wang, A Karpova, MA Gritsenko, JE Kyle, S Cao, Y Li, D Rykunov, ... Cancer cell 39 (4), 509-528. e20, 2021 | 390 | 2021 |
| The human tumor atlas network: charting tumor transitions across space and time at single-cell resolution O Rozenblatt-Rosen, A Regev, P Oberdoerffer, T Nawy, A Hupalowska, ... Cell 181 (2), 236-249, 2020 | 382 | 2020 |
| Proteogenomic characterization of endometrial carcinoma Y Dou, EA Kawaler, DC Zhou, MA Gritsenko, C Huang, L Blumenberg, ... Cell 180 (4), 729-748. e26, 2020 | 325 | 2020 |
| Proteogenomic characterization of pancreatic ductal adenocarcinoma L Cao, C Huang, DC Zhou, Y Hu, TM Lih, SR Savage, K Krug, DJ Clark, ... Cell 184 (19), 5031-5052. e26, 2021 | 277 | 2021 |
| Systematic functional annotation of somatic mutations in cancer PKS Ng, J Li, KJ Jeong, S Shao, H Chen, YH Tsang, S Sengupta, Z Wang, ... Cancer cell 33 (3), 450-462. e10, 2018 | 245 | 2018 |
| Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma C Huang, L Chen, SR Savage, RV Eguez, Y Dou, Y Li, ... Cancer cell 39 (3), 361-379. e16, 2021 | 219 | 2021 |
| Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer D Cui Zhou, RG Jayasinghe, S Chen, JM Herndon, MD Iglesia, P Navale, ... Nature genetics 54 (9), 1390-1405, 2022 | 81 | 2022 |
| Integrated proteogenomic characterization of clear cell renal cell carcinoma DJ Clark, SM Dhanasekaran, F Petralia, J Pan, X Song, Y Hu, ... Cell 180 (1), 207, 2020 | 52 | 2020 |
| Group MCW MH Bailey, C Tokheim, E Porta-Pardo, S Sengupta, D Bertrand, ... Cancer Genome Atlas Research N, Lawrence MS, Godzik A, Lopez-Bigas N, Stuart …, 2018 | 44 | 2018 |
| Discovery of driver non-coding splice-site-creating mutations in cancer S Cao, DC Zhou, C Oh, RG Jayasinghe, Y Zhao, CJ Yoon, ... Nature communications 11 (1), 5573, 2020 | 29 | 2020 |
| MSIsensor-ct: microsatellite instability detection using cfDNA sequencing data X Han, S Zhang, DC Zhou, D Wang, X He, D Yuan, R Li, J He, X Duan, ... Briefings in Bioinformatics 22 (5), bbaa402, 2021 | 24 | 2021 |
| Proteogenomic data and resources for pan-cancer analysis Y Li, Y Dou, FDV Leprevost, Y Geffen, AP Calinawan, F Aguet, Y Akiyama, ... Cancer cell 41 (8), 1397-1406, 2023 | 23 | 2023 |
| Pan-cancer proteogenomics connects oncogenic drivers to functional states Y Li, E Porta-Pardo, C Tokheim, MH Bailey, TM Yaron, V Stathias, ... Cell 186 (18), 3921-3944. e25, 2023 | 19 | 2023 |
| Pan-cancer analysis of post-translational modifications reveals shared patterns of protein regulation Y Geffen, S Anand, Y Akiyama, TM Yaron, Y Song, JL Johnson, ... Cell 186 (18), 3945-3967. e26, 2023 | 18 | 2023 |
| Spatially interacting phosphorylation sites and mutations in cancer K Huang, AD Scott, DC Zhou, LB Wang, A Weerasinghe, A Elmas, R Liu, ... Nature communications 12 (1), 2313, 2021 | 18 | 2021 |
| Epigenetic and transcriptomic characterization reveals progression markers and essential pathways in clear cell renal cell carcinoma Y Wu, NV Terekhanova, W Caravan, N Naser Al Deen, P Lal, S Chen, ... Nature communications 14 (1), 1681, 2023 | 14 | 2023 |
